Jumpcode Genomics Raises $21M in Series B Funding

20 Feb, 2021

Jumpcode Genomics Raises $21M in Series B Funding
Photo by Andrew Whitmore on Unsplash

– Jumpcode Genomics is a San Diego, CA-based genome technology company focused on improving the understanding of human disease.
– The company raised $21m in Series B funding.
– The round was co-led by Baird Capital and Arboretum Ventures with participation from existing investor LYZZ Capital.
– In conjunction with the funding, Frank Witney joined Jumpcode’s Board of Directors.

Biotechnology Health Care North America Wellness
Crunchbase icon

Content report

The following text will be sent to our editors: